5 mg/dL) were more likely to be febrile. In the majority of the patients, fever subsided 24 to 72 hours after supplementation of vitamin B12 and/or folate, suggesting the rapid correction of ineffective hematopoiesis. A phase 3 comparative review of literature highlighting pyrexia in megaloblastic http://www.selleckchem.com/products/Sorafenib-Tosylate.html anemia is presented in table 1. Carpenter et al.6 described a 38 year old female patient Inhibitors,research,lifescience,medical who presented
with chronic, low-grade intermittent fever (37.8°C), mild macrocytosis (MCV=104 fL), and normal hematocrit secondary to chronic atrophic gastritis, low vitamin B12 (115 pg/mL, reference range: 190-900 pg/mL), and co-existent proximal intestinal type gastric adenocarcinoma. The pathophysiological mechanism for her pyrexia could have been attributed to either nutritional deficiency secondary to chronic atrophic gastritis of pernicious anemia or release of tumoral cytokines (Interleukin-6); or both. However, response Inhibitors,research,lifescience,medical to vitamin B12 supplementation therapy was not documented in that case, and the patient expired due to metastatic disease following gastrectomy. Negi et al.7 reported a case of anicteric male with pyrexia (39.7°C), bicytopenia, and macrocytosis
(MCV=105 fL) secondary to B12 deficiency (105 pg/mL). Singanayagam et al.8 reported a young male with pyrexia Inhibitors,research,lifescience,medical of 6 weeks’ duration (38.8°C), severe pancytopenia, and mild hyperbilirubinemia secondary to folate deficiency (1.2 ng/mL, reference range: 5-24 ng/mL) and low normal vitamin B12 (202 pg/mL). The present report described Inhibitors,research,lifescience,medical a case of megaloblastic anemia in a middle-aged female patient, who presented with low-grade pyrexia, pancytopenia, macrocytosis (114.3 fL), very high LDH (10,550 IU/L, reference range: 225-420 IU/L), and mild unconjugated hyperbilirubinemia;
secondary to combined deficiency of B12 (59.6 pg/mL) Inhibitors,research,lifescience,medical and folate (3.9 ng/mL). In all the three cases (including the present one) as was described above, pyrexia subsided 24 to 72 hours after initiation of supplementation therapy. Table 1 Comparison of the present case of pyrexia and megaloblastic anemia with similar cases published in the literature The exact cause of fever in megaloblastic anemia is unknown and at present, seems more hypothetical rather than conclusive. Association of pyrexia and megaloblastic anemia Anacetrapib appears to be causal, whereas in other types of anemias, it seems more coincidental. Megaloblastic anemia is a panmyelosis, characterized by hypercellular marrow and ineffective hematopoiesis. Premature destruction of hematopoietic precursors possibly releases intracellular substances, which might function as systemic pyrogens. As was suggested by the researchers, dramatic response to B12 and/or folate supplementation (within 24 to 72 hours) strongly supports the above-said hypothesis.